DE60115062D1 - Ein thiazolidindionderivat und seine verwendung als antidiabetikum - Google Patents
Ein thiazolidindionderivat und seine verwendung als antidiabetikumInfo
- Publication number
- DE60115062D1 DE60115062D1 DE60115062T DE60115062T DE60115062D1 DE 60115062 D1 DE60115062 D1 DE 60115062D1 DE 60115062 T DE60115062 T DE 60115062T DE 60115062 T DE60115062 T DE 60115062T DE 60115062 D1 DE60115062 D1 DE 60115062D1
- Authority
- DE
- Germany
- Prior art keywords
- antidible
- indion
- thiazolide
- derivative
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0021784 | 2000-09-05 | ||
GBGB0021784.4A GB0021784D0 (en) | 2000-09-05 | 2000-09-05 | Novel pharmaceutical |
PCT/GB2001/003996 WO2002020520A1 (en) | 2000-09-05 | 2001-09-05 | A thiazolidinedione derivative and its use as antidiabetic |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60115062D1 true DE60115062D1 (de) | 2005-12-22 |
DE60115062T2 DE60115062T2 (de) | 2006-06-29 |
Family
ID=9898884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60115062T Expired - Fee Related DE60115062T2 (de) | 2000-09-05 | 2001-09-05 | Thiazolidindionderivat und seine verwendung als antidiabetikum |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040044043A1 (de) |
EP (1) | EP1315724B1 (de) |
JP (1) | JP2004508370A (de) |
KR (1) | KR100769008B1 (de) |
CN (1) | CN1239501C (de) |
AT (1) | ATE310000T1 (de) |
AU (1) | AU2001284285A1 (de) |
CY (1) | CY1105354T1 (de) |
DE (1) | DE60115062T2 (de) |
DK (1) | DK1315724T3 (de) |
ES (1) | ES2248385T3 (de) |
GB (1) | GB0021784D0 (de) |
HK (1) | HK1057751A1 (de) |
WO (1) | WO2002020520A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
DK1448559T3 (da) * | 2001-11-21 | 2007-04-30 | Smithkline Beecham Plc | 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel |
DE102005034406A1 (de) * | 2005-07-22 | 2007-02-01 | Ratiopharm Gmbh | Neue Salze von Rosiglitazon |
US7435741B2 (en) * | 2006-05-09 | 2008-10-14 | Teva Pharmaceutical Industries, Ltd. | 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
EP2043744A2 (de) * | 2006-07-13 | 2009-04-08 | SmithKline Beecham Corporation | Chemische verbindungen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
US5741803A (en) * | 1992-09-05 | 1998-04-21 | Smithkline Beecham Plc | Substituted thiazolidinedionle derivatives |
GB9726566D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
GB9726568D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
GB9726563D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
-
2000
- 2000-09-05 GB GBGB0021784.4A patent/GB0021784D0/en not_active Ceased
-
2001
- 2001-09-05 DK DK01963256T patent/DK1315724T3/da active
- 2001-09-05 US US10/363,456 patent/US20040044043A1/en not_active Abandoned
- 2001-09-05 AU AU2001284285A patent/AU2001284285A1/en not_active Abandoned
- 2001-09-05 DE DE60115062T patent/DE60115062T2/de not_active Expired - Fee Related
- 2001-09-05 AT AT01963256T patent/ATE310000T1/de not_active IP Right Cessation
- 2001-09-05 KR KR1020037003268A patent/KR100769008B1/ko not_active IP Right Cessation
- 2001-09-05 ES ES01963256T patent/ES2248385T3/es not_active Expired - Lifetime
- 2001-09-05 WO PCT/GB2001/003996 patent/WO2002020520A1/en active IP Right Grant
- 2001-09-05 CN CNB018180264A patent/CN1239501C/zh not_active Expired - Fee Related
- 2001-09-05 EP EP01963256A patent/EP1315724B1/de not_active Expired - Lifetime
- 2001-09-05 JP JP2002525141A patent/JP2004508370A/ja not_active Withdrawn
-
2003
- 2003-11-25 HK HK03108591A patent/HK1057751A1/xx not_active IP Right Cessation
-
2006
- 2006-01-23 CY CY20061100083T patent/CY1105354T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR100769008B1 (ko) | 2007-10-22 |
ES2248385T3 (es) | 2006-03-16 |
JP2004508370A (ja) | 2004-03-18 |
DE60115062T2 (de) | 2006-06-29 |
AU2001284285A1 (en) | 2002-03-22 |
HK1057751A1 (en) | 2004-04-16 |
GB0021784D0 (en) | 2000-10-18 |
DK1315724T3 (da) | 2006-02-20 |
WO2002020520A1 (en) | 2002-03-14 |
CN1471529A (zh) | 2004-01-28 |
KR20030027112A (ko) | 2003-04-03 |
CN1239501C (zh) | 2006-02-01 |
CY1105354T1 (el) | 2010-03-03 |
US20040044043A1 (en) | 2004-03-04 |
EP1315724B1 (de) | 2005-11-16 |
EP1315724A1 (de) | 2003-06-04 |
ATE310000T1 (de) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105354T1 (el) | Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο | |
DK1349855T3 (da) | 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt | |
DE60124119D1 (de) | Ein thiazolidindionderivat und seine verwendung als antidiabetikum | |
CY1107252T1 (el) | Τρυγικο αλας παραγωγου της θειζολιδινοδιονης | |
AP1814A (en) | Tartrate salts of thiazolidinedione derivative. | |
AP1715A (en) | The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione | |
DE60212434D1 (de) | Rosiglitazon-edisylate und ihre verwendung als antidiabetika | |
MXPA02012100A (es) | Sal de tiazodilindiona para el tratamiento de la diabetes mellitus. | |
AP2002002684A0 (en) | 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical | |
DE60217168D1 (de) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dion-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff | |
CY1107767T1 (el) | Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο | |
EA200300232A1 (ru) | Тартратные соли производного тиазолидиндиона |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |